SHANEIKA MCKENZIE: Open Payments
NPI 1083226013 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,604 in 74 payments from 20 companies in 2025. Trend: 2023 $866 · 2024 $2,383 · 2025 $1,604
Food & beverage: $1,604
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $177 |
| PFIZER INC. | 9 | $175 |
| AstraZeneca Pharmaceuticals LP | 10 | $162 |
| Amgen Inc. | 5 | $145 |
| ABBVIE INC. | 5 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $86 |
| BridgeBio Pharma, Inc. | 3 | $86 |
| Lilly USA, LLC | 4 | $79 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
Products named: ELIQUIS, OTEZLA, Kerendia, Ozempic, BREZTRI, CAPLYTA, Attruby, VRAYLAR.
Industry payments across CT — which companies pay providers there.
